SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001178913-21-003019
Filing Date
2021-09-17
Accepted
2021-09-17 16:06:33
Documents
7
Period of Report
2021-09-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A zk2126591.htm DEF 14A 285944
2 image9.jpg GRAPHIC 64788
3 image10.jpg GRAPHIC 66850
4 sc2.jpg GRAPHIC 2276
5 sc3.jpg GRAPHIC 1742
6 sc4.jpg GRAPHIC 5537
7 sc.jpg GRAPHIC 4665
  Complete submission text file 0001178913-21-003019.txt   488423
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38807 | Film No.: 211260461
SIC: 2834 Pharmaceutical Preparations